BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26179329)

  • 1. Neoadjuvant radiation therapy does not increase perioperative morbidity among patients undergoing gastrectomy for gastric cancer.
    Sun Z; Nussbaum DP; Speicher PJ; Czito BG; Tyler DS; Blazer DG
    J Surg Oncol; 2015 Jul; 112(1):46-50. PubMed ID: 26179329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative Morbidity and Mortality Rates are Not Increased for Patients with Gastric and Gastroesophageal Cancer Who Undergo Preoperative Chemoradiation Therapy.
    Badgwell B; Ajani J; Blum M; Ho L; Fournier K; Chiang YJ; Matamoros A; Das P; Mansfield P
    Ann Surg Oncol; 2016 Jan; 23(1):156-62. PubMed ID: 26059652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Waiting Time from Diagnosis to Treatment and Survival in Patients with Curable Gastric Cancer: A Population-Based Study in the Netherlands.
    Brenkman HJF; Visser E; van Rossum PSN; Siesling S; van Hillegersberg R; Ruurda JP
    Ann Surg Oncol; 2017 Jul; 24(7):1761-1769. PubMed ID: 28353020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment trends and predictors of adjuvant and neoadjuvant therapy for gastric adenocarcinoma in the United States.
    Sherman KL; Merkow RP; Bilimoria KY; Wang CE; Mulcahy MF; Benson AB; Bentrem DJ
    Ann Surg Oncol; 2013 Feb; 20(2):362-70. PubMed ID: 22890592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative therapy and long-term survival in gastric cancer: One size does not fit all.
    Biondi A; Agnes A; Del Coco F; Pozzo C; Strippoli A; D'Ugo D; Persiani R
    Surg Oncol; 2018 Sep; 27(3):575-583. PubMed ID: 30217321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morbidity and mortality after total gastrectomy for gastric malignancy using the American College of Surgeons National Surgical Quality Improvement Program database.
    Bartlett EK; Roses RE; Kelz RR; Drebin JA; Fraker DL; Karakousis GC
    Surgery; 2014 Aug; 156(2):298-304. PubMed ID: 24947651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Neoadjuvant Chemoradiation on Anastomotic Leak and Additional 30-Day Morbidity and Mortality in Patients Undergoing Total Gastrectomy for Gastric Cancer.
    Haskins IN; Kroh MD; Amdur RL; Ponksy JL; Rodriguez JH; Vaziri K
    J Gastrointest Surg; 2017 Oct; 21(10):1577-1583. PubMed ID: 28744744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of ypT, ypN, and Adjuvant Therapy on Survival in Gastric Cancer Patients Treated with Perioperative Chemotherapy and Radical Surgery.
    Coimbra FJF; de Jesus VHF; Ribeiro HSC; Diniz AL; de Godoy AL; de Farias IC; Felismino T; Mello CAL; Almeida MF; Begnami MDFS; Dias-Neto E; Riechelmann RSP; da Costa WL
    Ann Surg Oncol; 2019 Oct; 26(11):3618-3626. PubMed ID: 31222685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of repeat staging laparoscopy in locoregionally advanced gastric or gastroesophageal cancer after neoadjuvant therapy.
    Cardona K; Zhou Q; Gönen M; Shah MA; Strong VE; Brennan MF; Coit DG
    Ann Surg Oncol; 2013 Feb; 20(2):548-54. PubMed ID: 22941159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low creatinine clearance is a risk factor for D2 gastrectomy after neoadjuvant chemotherapy.
    Hayashi T; Aoyama T; Tanabe K; Nishikawa K; Ito Y; Ogata T; Cho H; Morita S; Miyashita Y; Tsuburaya A; Sakamoto J; Yoshikawa T
    Ann Surg Oncol; 2014 Sep; 21(9):3015-22. PubMed ID: 24715213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
    Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
    Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of docetaxel and S-1 (DS) as neoadjuvant chemotherapy for clinical stage III resectable gastric cancer.
    Oki E; Emi Y; Kusumoto T; Sakaguchi Y; Yamamoto M; Sadanaga N; Shimokawa M; Yamanaka T; Saeki H; Morita M; Takahashi I; Hirabayashi N; Sakai K; Orita H; Aishima S; Kakeji Y; Yamaguchi K; Yoshida K; Baba H; Maehara Y
    Ann Surg Oncol; 2014 Jul; 21(7):2340-6. PubMed ID: 24604583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of obesity on perioperative complications and long-term survival of patients with gastric cancer.
    Bickenbach KA; Denton B; Gonen M; Brennan MF; Coit DG; Strong VE
    Ann Surg Oncol; 2013 Mar; 20(3):780-7. PubMed ID: 22976377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morbidity and mortality associated with gastrectomy for gastric cancer.
    Papenfuss WA; Kukar M; Oxenberg J; Attwood K; Nurkin S; Malhotra U; Wilkinson NW
    Ann Surg Oncol; 2014 Sep; 21(9):3008-14. PubMed ID: 24700300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer.
    Inoue K; Nakane Y; Kogire M; Fujitani K; Kimura Y; Imamura H; Tamura S; Okano S; Kwon AH; Kurokawa Y; Shimokawa T; Takiuchi H; Tsujinaka T; Furukawa H
    Eur J Surg Oncol; 2012 Feb; 38(2):143-9. PubMed ID: 22154885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy, radical resection with intraoperative radiation therapy (IORT): improved treatment for gastric adenocarcinoma.
    Weese JL; Harbison SP; Stiller GD; Henry DH; Fisher SA
    Surgery; 2000 Oct; 128(4):564-71. PubMed ID: 11015089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative chemotherapy for resectable gastroesophageal cancer: a single-center experience.
    Molina R; Lamarca A; Martínez-Amores B; Gutiérrez A; Blázquez A; López A; Granell J; Álvarez-Mon M
    Eur J Surg Oncol; 2013 Aug; 39(8):814-22. PubMed ID: 23755989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feeding jejunostomy tube placement during resection of gastric cancers.
    Sun Z; Shenoi MM; Nussbaum DP; Keenan JE; Gulack BC; Tyler DS; Speicher PJ; Blazer DG
    J Surg Res; 2016 Jan; 200(1):189-94. PubMed ID: 26248478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative Therapy for Gastric Adenocarcinoma is Protective for Poor Oncologic Outcomes in Patients with Complications After Gastrectomy.
    Vicente D; Ikoma N; Chiang YJ; Fournier K; Tzeng CD; Song S; Mansfield P; Ajani J; Badgwell BD
    Ann Surg Oncol; 2018 Sep; 25(9):2720-2730. PubMed ID: 29987602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery of gastric cancer and esophageal cancer: Does age matter?
    Nienhueser H; Kunzmann R; Sisic L; Blank S; Strowitzk MJ; Bruckner T; Jäger D; Weichert W; Ulrich A; Büchler MW; Ott K; Schmidt T
    J Surg Oncol; 2015 Sep; 112(4):387-95. PubMed ID: 26303645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.